(Q34171741)

31 July 2017

1 reference

title

P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions (English)

1 reference

31 July 2017

Yamsani Shravan Kumar

1

1 reference

31 July 2017

Devandla Adukondalu

2

1 reference

31 July 2017

Dharani Sathish

3

1 reference

31 July 2017

Yamsani Vamshi Vishnu

4

1 reference

31 July 2017

Gannu Ramesh

5

1 reference

31 July 2017

Athukuri Bharagavi Latha

6

1 reference

31 July 2017

Palem Chinna Reddy

7

1 reference

31 July 2017

Manda Sarangapani

8

1 reference

31 July 2017

Yamsani Madhusudan Rao

9

1 reference

31 July 2017

1 January 2010

1 reference

Drug Metabolism and Drug Interactions

31 July 2017

1 reference

31 July 2017

25

1 reference

31 July 2017

3-16

1 reference

31 July 2017

1-4

1 reference

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

31 July 2017

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The drug efflux-metabolism alliance: biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Intestinal drug efflux: formulation and food effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Carrier-mediated intestinal transport of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Structure of the multidrug resistance P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

How does P-glycoprotein recognize its substrates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The effects of fruit juices on drug disposition: a new model for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effects of ketoconazole on digoxin absorption and disposition in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Pharmacophore modeling of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Genetic contribution to variable human CYP3A-mediated metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Grapefruit juice-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Herb-drug interactions: review and assessment of report reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The effect of garlic supplements on the pharmacokinetics of saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Saquinavir. Clinical pharmacology and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Transport, metabolism and elimination mechanisms of anti-HIV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Drug interactions of HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Effects of Curcuma spp. on P-glycoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2010.006

21 January 2018

Identifiers

DOI

10.1515/DMDI.2010.006

1 reference

31 July 2017

1 reference